InvestSMART

Healius Limited (ASX: HLS) - Announcements

Current share price for HLS : $0.380 0.02 (5.56%)+

ASX company news and announcements for Healius Limited (HLS) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Healius Limited (HLS) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Healius Limited (HLS), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Healius Limited (HLS)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$276 Appointment of Group Executive, Healius Pathology 11 May 2023 9:40AM $3.050 $0.380 fallen by 87.54%
$276 ACL: Takeover offer - receipt of Target's Statement 5 May 2023 9:06AM $3.050 $0.380 fallen by 87.54%
$276 Lodgement of Target's Statement 4 May 2023 8:51AM $3.040 $0.380 fallen by 87.50%
$276 Notification of cessation of securities - HLS 2 May 2023 9:18AM $3.020 $0.380 fallen by 87.42%
$276 Update on DH sale, debt covenant waiver and consensus 2 May 2023 9:04AM $3.020 $0.380 fallen by 87.42%
$276 Update on ASX waiver for issue of performance rights 1 May 2023 2:48PM $3.020 $0.380 fallen by 87.42%
$276 Notification of cessation of securities - HLS 28 Apr 2023 2:22PM $3.005 $0.380 fallen by 87.35%
$276 Notification of cessation of securities - HLS 28 Apr 2023 1:48PM $3.005 $0.380 fallen by 87.35%
$276 ACL:Completion of dispatch of replacement bidder's statement 21 Apr 2023 6:58PM $3.070 $0.380 fallen by 87.62%
$276 ACL: Commencement of dispatch of replacement bidder's stmt 21 Apr 2023 5:53PM $3.070 $0.380 fallen by 87.62%
$276 Electronic Delivery of Target's Statement 19 Apr 2023 5:36PM $3.030 $0.380 fallen by 87.46%
$276 TOV: HLS Panel Declines to Conduct Proceedings 17 Apr 2023 9:54AM $3.130 $0.380 fallen by 87.86%
$276 ACL: ASX announcement - Replacement Bidder's Statement 14 Apr 2023 6:03PM $3.130 $0.380 fallen by 87.86%
$276 ACL: Replacement Bidder's Statement 14 Apr 2023 6:00PM $3.130 $0.380 fallen by 87.86%
$276 ACL: First Supplementary Bidder's Statement 14 Apr 2023 5:59PM $3.130 $0.380 fallen by 87.86%
$276 TOV: HLS Panel Receives Application 29 Mar 2023 10:01AM $3.030 $0.380 fallen by 87.46%
$276 Company Secretary Appointment/Resignation 28 Mar 2023 3:58PM $3.050 $0.380 fallen by 87.54%
$276 Directors' Statement re Takeover 27 Mar 2023 8:39AM $2.910 $0.380 fallen by 86.94%
$276 Appointment of Charlie Taylor as a Non-executive Director 21 Mar 2023 9:39AM $3.010 $0.380 fallen by 87.38%
$276 Initial Directors Interest Notice 21 Mar 2023 9:38AM $3.010 $0.380 fallen by 87.38%
$276 Company Secretary Appointment/Resignation 21 Mar 2023 8:13AM $3.010 $0.380 fallen by 87.38%
$276 Becoming a substantial holder from ACL 20 Mar 2023 10:19AM $2.930 $0.380 fallen by 87.03%
$276 ACL: People to whom information is to be sent 20 Mar 2023 10:18AM $2.930 $0.380 fallen by 87.03%
$276 Off-market takeover bid from ACL 20 Mar 2023 9:55AM $2.780 $0.380 fallen by 86.33%
$276 ACL: Investor Webinar - Takeover Offer for Healius 20 Mar 2023 8:33AM $2.780 $0.380 fallen by 86.33%

376 - 400 of 1062 results

Page 16 of 43

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.